| - SMTL ID
- 4wm7.1
- Ligands
- 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE
- Polypeptides
- VP1; VP2; VP3; VP4
- Oligo-state
- hetero-1-1-1-1-mer
|
| - SMTL ID
- 4wm7.2
- Ligands
- 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE
- Polypeptides
- VP1; VP2; VP3; VP4
- Oligo-state
- hetero-5-5-5-5-mer
|
| - SMTL ID
- 4wm7.3
- Ligands
- 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE
- Polypeptides
- VP1; VP2; VP3; VP4
- Oligo-state
- hetero-6-6-6-6-mer
|
| - SMTL ID
- 4wm7.4
- Ligands
- 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE
- Polypeptides
- VP1; VP2; VP3; VP4
- Oligo-state
- hetero-1-1-1-1-mer
|
| - SMTL ID
- 4wm7.5
- Ligands
- 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE
- Polypeptides
- VP1; VP2; VP3; VP4
- Oligo-state
- hetero-15-15-15-15-mer
|